Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,386 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM.
Williams MJ, Amezcua L, Chinea A, Cohan S, Okai A, Okuda DT, Vargas W, Belviso N, Božin I, Jiang X, Lewin JB, Lyons J, Shen C, England SM, Grimes N. Williams MJ, et al. Among authors: shen c. Neurol Ther. 2023 Oct;12(5):1669-1682. doi: 10.1007/s40120-023-00517-1. Epub 2023 Jun 24. Neurol Ther. 2023. PMID: 37354276 Free PMC article.
Assessing the utility of magnetic resonance imaging-based "SuStaIn" disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosis.
Jiang X, Shen C, Caba B, Arnold DL, Elliott C, Zhu B, Fisher E, Belachew S, Gafson AR. Jiang X, et al. Among authors: shen c. Mult Scler Relat Disord. 2023 Sep;77:104869. doi: 10.1016/j.msard.2023.104869. Epub 2023 Jul 2. Mult Scler Relat Disord. 2023. PMID: 37459715 Free article.
Network meta-analysis of MS DMTs: In response to "Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis" by Chen et al.
Jomaa K, Gianinazzi M, Guerra A, Shen C, Debray T. Jomaa K, et al. Among authors: shen c. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):27-28. doi: 10.1016/j.japh.2023.07.006. J Am Pharm Assoc (2003). 2024. PMID: 38309787 No abstract available.
10,386 results
You have reached the last available page of results. Please see the User Guide for more information.